<span item_type="fundamental" item_id="f1b7ffc43b5392f9b96bbdb9e8963f5c" counter_id="ST/US/ATRO" env="prod"></span><span item_type="announcement" item_id="647987115594809601" env="prod"></span><p>Revenue: As of FY2026 Q1, the actual value is USD 230.62 M, beating the estimate of USD 227.84 M.</p><p>EPS: As of FY2026 Q1, the actual value is USD 0.67.</p><p>EBIT: As of FY2026 Q1, the actual value is USD 29.57 M.</p><p></p><h3>Consolidated Financial Performance</h3><h4>Gross Profit</h4><ul><li>Gross Profit for the three months ended April 4, 2026, was $75,133 thousand, up from $60,849 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Gross Margin increased to 32.6% for the three months ended April 4, 2026, from 29.5% for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li></ul><h4>Operating Expenses</h4><ul><li>Research and Development Expenses were $12,089 thousand for the three months ended April 4, 2026, compared to $11,067 thousand for the prior year period.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Selling, General and Administrative Expenses (SG&amp;A) were $35,814 thousand for the three months ended April 4, 2026, a decrease from $36,645 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>SG&amp;A Expenses as a Percentage of Sales improved to 15.5% for the three months ended April 4, 2026, from 17.8% for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li></ul><h4>Net Income</h4><ul><li>Net Income significantly increased to $25,540 thousand for the three months ended April 4, 2026, from $9,528 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li></ul><h4>Other Financials</h4><ul><li>Interest Expense, Net was $2,336 thousand for the three months ended April 4, 2026, down from $3,150 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>The Effective Tax Rate was -3.0% for the three months ended April 4, 2026, compared to 6.3% for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li></ul><h4>Backlog and Bookings</h4><ul><li>Bookings for the three months ended April 4, 2026, totaled $290.4 million, resulting in a book-to-bill ratio of 1.26:1.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Trailing twelve months bookings were $935.1 million, with a book-to-bill ratio of 1.05:1.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Backlog at April 4, 2026, was $734.3 million, an increase from $674.5 million at December 31, 2025, and $673.0 million at March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li></ul><h3>Segment Results of Operations</h3><h4>Aerospace Segment</h4><ul><li>Operating Profit for the three months ended April 4, 2026, was $35,332 thousand, a substantial increase from $22,264 thousand for the prior year period.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Operating Margin improved to 16.5% for the three months ended April 4, 2026, from 11.6% for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Sales by Market for the three months ended April 4, 2026, included Commercial Transport at $156,419 thousand, Military Aircraft at $33,502 thousand, and General Aviation at $21,449 thousand.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Sales by Product Line for the same period included Inflight Entertainment &amp; Connectivity at $110,748 thousand, Lighting &amp; Safety at $52,807 thousand, Flight Critical Electrical Power at $24,763 thousand, and Seat Motion at $19,879 thousand.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Total Assets for the Aerospace segment were $604,480 thousand at April 4, 2026, up from $570,294 thousand at December 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Backlog for the Aerospace segment reached $651,364 thousand at April 4, 2026, compared to $600,803 thousand at December 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Bookings for the quarter were $264.4 million, with a book-to-bill ratio of 1.24:1.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Depreciation and Amortization was $5,379 thousand for the three months ended April 4, 2026, versus $4,498 thousand in the prior year period.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Capital Expenditures were $10,731 thousand for the three months ended April 4, 2026, significantly higher than $2,082 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li></ul><h4>Test Systems Segment</h4><ul><li>Operating Profit was $403 thousand for the three months ended April 4, 2026, a turnaround from an Operating Loss of - $2,223 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Operating Margin improved to 2.4% for the three months ended April 4, 2026, from -15.3% for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>All sales in the Test Systems segment were to the Government and Defense Market.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Total Assets for the Test Systems segment were $120,115 thousand at April 4, 2026, a slight increase from $119,603 thousand at December 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Backlog for the Test Systems segment was $82,960 thousand at April 4, 2026, compared to $73,692 thousand at December 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Bookings for the quarter were $26.1 million, with a book-to-bill ratio of 1.55:1.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Depreciation and Amortization was $505 thousand for the three months ended April 4, 2026, down from $1,078 thousand for the prior year period.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Capital Expenditures were $429 thousand for the three months ended April 4, 2026, compared to $23 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li></ul><h3>Cash Flow and Liquidity</h3><ul><li>Net Cash Provided by Operating Activities was $10,606 thousand for the three months ended April 4, 2026, a decrease from $20,642 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Net Cash Used by Investing Activities was - $11,160 thousand for the three months ended April 4, 2026, compared to - $2,105 thousand for the prior year period.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Net Cash Used by Financing Activities was - $5,501 thousand for the three months ended April 4, 2026, an improvement from - $11,371 thousand for the three months ended March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Cash and Cash Equivalents at the end of the period were $11,867 thousand on April 4, 2026, down from $25,948 thousand on March 29, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Net Debt was $331.1 million at April 4, 2026, increasing from $324.8 million at December 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li><li>Astronics Corporation was in compliance with all covenants under its financing arrangements as of April 4, 2026.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><p>Astronics Corporation aims to increase value through internal technology development and strategic acquisitions, providing innovative solutions to targeted markets.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span> The company anticipates sufficient cash flow from operations to fund capital expenditures and other obligations, while actively evaluating initiatives like manufacturing efficiency, cost reduction, and supply chain management to enhance profitability and cash generation.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span> Favorable impacts on its effective tax rate and cash tax rate are expected in future years due to the One Big Beautiful Bill Act, allowing for immediate expensing of certain domestic R&amp;D and capital expenditures.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/8063/000000806326000025/atro-20260404.htm"></span></p>

Astronics | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 230.62 M